University of Nebraska Medical Center

Moderna joins CEPI’s 100 Days Mission to advance pandemic preparedness

Fierce Biotech

Moderna is shifting attention to the next pandemic, whatever it may be, in a new partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) to condense vaccine development timelines down to 100 days.

The famed biotech is the latest to join CEPI’s 100 Days Mission, which aims to strengthen pandemic preparedness and speed up public health initiatives to respond to the next global viral threat. Moderna will engage its mRNA platform, which was able to quickly churn out a vaccine during the COVID-19 crisis, according to a Monday press release.

Moderna and CEPI believe the platform could go even faster, though. “Future outbreaks are inevitable, but another pandemic is not. Thanks to the scientific and technological innovations advanced during COVID-19, the world now has the tools and capabilities to prevent the next outbreak from spiraling into a global catastrophe,” said CEPI CEO Richard Hatchett, M.D. “Chief among them is the now proven mRNA vaccine technology, which can be used to develop safe and effective vaccines with remarkable speed that can be rapidly manufactured at scale.”

Leave a comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.